FDA Approves Durvalumab for Muscle Invasive Bladder Cancer By Ogkologos - May 2, 2025 635 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the NIAGARA study Source RELATED ARTICLESMORE FROM AUTHOR Worse Survival Observed Among Patients Diagnosed with Cancer During the First 2 Years of the COVID-19 Pandemic AI-Supported Mammography Screening Shows Favourable Outcomes Compared with Standard Double Reading ESMO Welcomes European Parliament Resolution Marking World Cancer Day MOST POPULAR 8-Year-Old Cancer Survivor Celebrates Recovery By Donating Her Birthday Gifts To... July 23, 2019 New Study Says At-Home Cancer Care May Lead to Fewer Hospitalizations... May 20, 2021 35-Year-Old Mom Has Been Living With Stage IV Breast Cancer For... March 25, 2020 Patient Exposure to Anticancer Drugs Subsequently Withdrawn from the FDA Accelerated... March 9, 2023 Load more HOT NEWS Seeing a Promising Future for Progress against Childhood Cancer Over 600 people in England set to benefit from innovative lung... High Tumour Mutation Burden Fails to Predict Response to Immune Checkpoint... Cancer in My Community: Expanding Access to Genetic Testing in Mexico
